Gabather
0.043
SEK
+4.88 %
Less than 1K followers
GABA
First North Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Ownership
Investor consensus
+4.88%
+6.44%
-65.6%
-59.65%
-66.37%
-89.87%
-97.19%
-96.84%
-98.98%
Gabather is a pharmaceutical company. Today, there is a business focus on developing drug candidates for the treatment of nerve diseases. Particular focus is on the stimulation of gamma-aminobutyric acid, which is the main inhibitory neurotransmitter in the brain. The drug candidates are today patented on a global level. Gabather was established in 2014 and is headquartered in Malmö.
Read moreMarket cap
10.16M SEK
Turnover
5.44K SEK
Revenue
-
EBIT %
-
P/E
-
Dividend yield-%
-
Financial calendar
30/6
2025
General meeting '25
28/8
2025
Interim report Q2'25
27/11
2025
Interim report Q3'25
All
Press releases
3rd party
ShowingAll content types
Gabather AB: KALLELSE TILL ÅRSSTÄMMA I GABATHER AB (PUBL)
Gabather AB offentliggör årsredovisning för räkenskapsåret 2024
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools